Skip to Main Content
Umbrella Alt Text
header search
Search
Advanced Search
Skip Nav Destination

Issues

Volume 23, Issue 5
1 May 2000
Issue Cover
All Issues
ISSN 0149-5992
EISSN 1935-5548
Search within issue
Impaired glucose tolerance: the irrepressible alpha-cell?
E Ipp
View articletitled, Impaired glucose tolerance: the irrepressible alpha-cell?
Open the PDF for in another window
Diabetes Care May 2000, Vol.23, 569-570. doi:https://doi.org/10.2337/diacare.23.5.569
Nighttime continuous subcutaneous insulin infusion revisited: a strategy for improving insulin delivery.
A Schiffrin
View articletitled, Nighttime continuous subcutaneous insulin infusion revisited: a strategy for improving insulin delivery.
Open the PDF for in another window
Diabetes Care May 2000, Vol.23, 571-573. doi:https://doi.org/10.2337/diacare.23.5.571
Therapeutic importance of subsets of type 2 diabetes?
J P Palmer
View articletitled, Therapeutic importance of subsets of type 2 diabetes?
Open the PDF for in another window
Diabetes Care May 2000, Vol.23, 574-575. doi:https://doi.org/10.2337/diacare.23.5.574
Insulin glargine (HOE901): first responsibilities: understanding the data and ensuring safety.
J Buse
View articletitled, Insulin glargine (HOE901): first responsibilities: understanding the data and ensuring safety.
Open the PDF for in another window
Diabetes Care May 2000, Vol.23, 576-578. doi:https://doi.org/10.2337/diacare.23.5.576
Use of insulin pump therapy at nighttime only for children 7-10 years of age with type 1 diabetes.
F R Kaufman; M Halvorson; C Kim; P Pitukcheewanont
View articletitled, Use of insulin pump therapy at nighttime only for children 7-10 years of age with type 1 diabetes.
Open the PDF for in another window
Diabetes Care May 2000, Vol.23, 579-582. doi:https://doi.org/10.2337/diacare.23.5.579
Use of insulin aspart, a fast-acting insulin analog, as the mealtime insulin in the management of patients with type 1 diabetes.
P Raskin; R A Guthrie; L Leiter; A Riis; L Jovanovic
View articletitled, Use of insulin aspart, a fast-acting insulin analog, as the mealtime insulin in the management of patients with type 1 diabetes.
Open the PDF for in another window
Diabetes Care May 2000, Vol.23, 583-588. doi:https://doi.org/10.2337/diacare.23.5.583
Consequences of a family history of type 1 and type 2 diabetes on the phenotype of patients with type 2 diabetes.
H Li; B Isomaa; M R Taskinen; L Groop; T Tuomi
View articletitled, Consequences of a family history of type 1 and type 2 diabetes on the phenotype of patients with type 2 diabetes.
Open the PDF for in another window
Diabetes Care May 2000, Vol.23, 589-594. doi:https://doi.org/10.2337/diacare.23.5.589
Diabetes in the Old Order Amish: characterization and heritability analysis of the Amish Family Diabetes Study.
W C Hsueh; B D Mitchell; R Aburomia; T Pollin; H Sakul; M Gelder Ehm; B K Michelsen; M J Wagner; P L St Jean; W C Knowler; D K Burns; C J Bell; A R Shuldiner
View articletitled, Diabetes in the Old Order Amish: characterization and heritability analysis of the Amish Family Diabetes Study.
Open the PDF for in another window
Diabetes Care May 2000, Vol.23, 595-601. doi:https://doi.org/10.2337/diacare.23.5.595
Sex differentials in predictors of mortality for patients with adult-onset diabetes: a population-based follow-up study in Beer-Sheva, Israel.
A Biderman; I Rosenblatt; S Rosen; L M Zangwill; R Shalev; M Friger; S Weitzman
View articletitled, Sex differentials in predictors of mortality for patients with adult-onset diabetes: a population-based follow-up study in Beer-Sheva, Israel.
Open the PDF for in another window
Diabetes Care May 2000, Vol.23, 602-605. doi:https://doi.org/10.2337/diacare.23.5.602
Screening techniques to identify people at high risk for diabetic foot ulceration: a prospective multicenter trial.
H Pham; D G Armstrong; C Harvey; L B Harkless; J M Giurini; A Veves
View articletitled, Screening techniques to identify people at high risk for diabetic foot ulceration: a prospective multicenter trial.
Open the PDF for in another window
Diabetes Care May 2000, Vol.23, 606-611. doi:https://doi.org/10.2337/diacare.23.5.606
Impact of diabetes on crash risks of truck-permit holders and commercial drivers.
C Laberge-Nadeau; G Dionne; J M Ekoé; P Hamet; D Desjardins; S Messier; U Maag
View articletitled, Impact of diabetes on crash risks of truck-permit holders and commercial drivers.
Open the PDF for in another window
Diabetes Care May 2000, Vol.23, 612-617. doi:https://doi.org/10.2337/diacare.23.5.612
Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial.
P J Lustman; K E Freedland; L S Griffith; R E Clouse
View articletitled, Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial.
Open the PDF for in another window
Diabetes Care May 2000, Vol.23, 618-623. doi:https://doi.org/10.2337/diacare.23.5.618
Heart rate in relation to insulin sensitivity and insulin secretion in nondiabetic subjects.
A Festa; R D'Agostino, Jr; C N Hales; L Mykkänen; S M Haffner
View articletitled, Heart rate in relation to insulin sensitivity and insulin secretion in nondiabetic subjects.
Open the PDF for in another window
Diabetes Care May 2000, Vol.23, 624-628. doi:https://doi.org/10.2337/diacare.23.5.624
Optimized basal-bolus therapy using a fixed mixture of 75% lispro and 25% NPL insulin in type 1 diabetes patients: no favorable effects on glycemic control, physiological responses to hypoglycemia, well-being, or treatment satisfaction.
M M Janssen; F J Snoek; N Masurel; R P Hoogma; W L Devillé; C Popp-Snijders; R J Heine
View articletitled, Optimized basal-bolus therapy using a fixed mixture of 75% lispro and 25% NPL insulin in type 1 diabetes patients: no favorable effects on glycemic control, physiological responses to hypoglycemia, well-being, or treatment satisfaction.
Open the PDF for in another window
Diabetes Care May 2000, Vol.23, 629-633. doi:https://doi.org/10.2337/diacare.23.5.629
Efficacy of injected liquid silicone in the diabetic foot to reduce risk factors for ulceration: a randomized double-blind placebo-controlled trial.
C H van Schie; A Whalley; L Vileikyte; T Wignall; S Hollis; A J Boulton
View articletitled, Efficacy of injected liquid silicone in the diabetic foot to reduce risk factors for ulceration: a randomized double-blind placebo-controlled trial.
Open the PDF for in another window
Diabetes Care May 2000, Vol.23, 634-638. doi:https://doi.org/10.2337/diacare.23.5.634
Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. U.S. Study Group of Insulin Glargine in Type 1 Diabetes.
R E Ratner; I B Hirsch; J L Neifing; S K Garg; T E Mecca; C A Wilson
View articletitled, Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. U.S. Study Group of Insulin Glargine in Type 1 Diabetes.
Open the PDF for in another window
Diabetes Care May 2000, Vol.23, 639-643. doi:https://doi.org/10.2337/diacare.23.5.639
Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo.
L Heinemann; R Linkeschova; K Rave; B Hompesch; M Sedlak; T Heise
View articletitled, Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo.
Open the PDF for in another window
Diabetes Care May 2000, Vol.23, 644-649. doi:https://doi.org/10.2337/diacare.23.5.644
Islet dysfunction in insulin resistance involves impaired insulin secretion and increased glucagon secretion in postmenopausal women with impaired glucose tolerance.
H Larsson; B Ahrén
View articletitled, Islet dysfunction in insulin resistance involves impaired insulin secretion and increased glucagon secretion in postmenopausal women with impaired glucose tolerance.
Open the PDF for in another window
Diabetes Care May 2000, Vol.23, 650-657. doi:https://doi.org/10.2337/diacare.23.5.650
Hemodynamic effects of acute hyperglycemia in type 2 diabetic patients.
R Marfella; F Nappo; L De Angelis; G Paolisso; M R Tagliamonte; D Giugliano
View articletitled, Hemodynamic effects of acute hyperglycemia in type 2 diabetic patients.
Open the PDF for in another window
Diabetes Care May 2000, Vol.23, 658-663. doi:https://doi.org/10.2337/diacare.23.5.658
Urinary transforming growth factor-beta1 and alpha1-microglobulin in children and adolescents with type 1 diabetes.
E Korpinen; A M Teppo; L Hukkanen; H K Akerblom; C Grönhagen-Riska; O Vaarala
View articletitled, Urinary transforming growth factor-beta1 and alpha1-microglobulin in children and adolescents with type 1 diabetes.
Open the PDF for in another window
Diabetes Care May 2000, Vol.23, 664-668. doi:https://doi.org/10.2337/diacare.23.5.664
Apolipoprotein E isoform polymorphisms are not associated with insulin resistance: the Framingham Offspring Study.
J B Meigs; J M Ordovas; L A Cupples; D E Singer; D M Nathan; E J Schaefer; P W Wilson
View articletitled, Apolipoprotein E isoform polymorphisms are not associated with insulin resistance: the Framingham Offspring Study.
Open the PDF for in another window
Diabetes Care May 2000, Vol.23, 669-674. doi:https://doi.org/10.2337/diacare.23.5.669
Repaglinide acutely amplifies pulsatile insulin secretion by augmentation of burst mass with no effect on burst frequency.
C B Juhl; N Pørksen; M Hollingdal; J Sturis; S Pincus; J D Veldhuis; A Dejgaard; O Schmitz
View articletitled, Repaglinide acutely amplifies pulsatile insulin secretion by augmentation of burst mass with no effect on burst frequency.
Open the PDF for in another window
Diabetes Care May 2000, Vol.23, 675-681. doi:https://doi.org/10.2337/diacare.23.5.675
National standards for diabetes self-management education. Task Force to Review and Revise the National Standards for Diabetes Self-Management Education Programs.
C Mensing; J Boucher; M Cypress; K Weinger; K Mulcahy; P Barta; G Hosey; W Kopher; A Lasichak; B Lamb; M Mangan; J Norman; J Tanja; L Yauk; K Wisdom; C Adams
View articletitled, National standards for diabetes self-management education. Task Force to Review and Revise the National Standards for Diabetes Self-Management Education Programs.
Open the PDF for in another window
Diabetes Care May 2000, Vol.23, 682-689. doi:https://doi.org/10.2337/diacare.23.5.682
American Diabetes Association annual meeting, 1999: dyslipidemia, endothelial dysfunction, and glycosylation.
Z T Bloomgarden
View articletitled, American Diabetes Association annual meeting, 1999: dyslipidemia, endothelial dysfunction, and glycosylation.
Open the PDF for in another window
Diabetes Care May 2000, Vol.23, 690-698. doi:https://doi.org/10.2337/diacare.23.5.690
Bilateral diabetic infarction of the anterior tibial muscle.
K Spengos; J C Wöhrle; J Binder; A Schwartz; M Hennerici
View articletitled, Bilateral diabetic infarction of the anterior tibial muscle.
Open the PDF for in another window
Diabetes Care May 2000, Vol.23, 699-701. doi:https://doi.org/10.2337/diacare.23.5.699a
Venlafaxine HCl in the treatment of painful peripheral diabetic neuropathy.
J A Kiayias; E D Vlachou; E Lakka-Papadodima
View articletitled, Venlafaxine HCl in the treatment of painful peripheral diabetic neuropathy.
Open the PDF for in another window
Diabetes Care May 2000, Vol.23, 699. doi:https://doi.org/10.2337/diacare.23.5.699b
Function of pancreatic islets isolated from a type 1 diabetic patient.
P Marchetti; F Dotta; Z Ling; R Lupi; S Del Guerra; C Santangelo; M Realacci; L Marselli; U Di Mario; R Navalesi
View articletitled, Function of pancreatic islets isolated from a type 1 diabetic patient.
Open the PDF for in another window
Diabetes Care May 2000, Vol.23, 701-703. doi:https://doi.org/10.2337/diacare.23.5.701
Circulating levels of coagulation factor XIII in subjects with type 2 diabetes and in their first-degree relatives.
M W Mansfield; H P Kohler; R A Ariëns; L J McCormack; P J Grant
View articletitled, Circulating levels of coagulation factor XIII in subjects with type 2 diabetes and in their first-degree relatives.
Open the PDF for in another window
Diabetes Care May 2000, Vol.23, 703-705. doi:https://doi.org/10.2337/diacare.23.5.703
Prevalence of diabetes in adult patients with Down's syndrome living in a residential home.
Y Ohyama; T Utsugi; T Uchiyama; T Hanaoka; S Tomono; M Kurabayashi
View articletitled, Prevalence of diabetes in adult patients with Down's syndrome living in a residential home.
Open the PDF for in another window
Diabetes Care May 2000, Vol.23, 705-706. doi:https://doi.org/10.2337/diacare.23.5.705a
Effect of aldose reductase inhibitor on cutaneous nerve fiber length in diabetic patients.
H Yasuda; A Hirai; M Joko; M Terada; T Kawabata; K Maeda; M Haneda; A Kashiwagi; T Maeda; R Kikkawa
View articletitled, Effect of aldose reductase inhibitor on cutaneous nerve fiber length in diabetic patients.
Open the PDF for in another window
Diabetes Care May 2000, Vol.23, 705. doi:https://doi.org/10.2337/diacare.23.5.705b
Effect of data management on a central server on HbA1c levels in insulin-requiring patients.
M B Davidson; G Lewis
View articletitled, Effect of data management on a central server on HbA1c levels in insulin-requiring patients.
Open the PDF for in another window
Diabetes Care May 2000, Vol.23, 706-707. doi:https://doi.org/10.2337/diacare.23.5.706
Prevalence of diabetes, impaired glucose tolerance, and impaired fasting glucose in a rural population of Korea, according to 1997 American Diabetes Association and 1985 World Health Organization criteria.
J Y Park; Y I Kim; C S Choi; Y E Chung; S W Kim; M S Lee; S I Lee; S K Hong; K U Lee
View articletitled, Prevalence of diabetes, impaired glucose tolerance, and impaired fasting glucose in a rural population of Korea, according to 1997 American Diabetes Association and 1985 World Health Organization criteria.
Open the PDF for in another window
Diabetes Care May 2000, Vol.23, 707-708. doi:https://doi.org/10.2337/diacare.23.5.707
Rapid remission of nephrotic-range proteinuria in a case of histologically proven diabetic nephropathy treated with an ACE inhibitor.
R Suzuki; A Shimada; K Konishi; T Saruta
View articletitled, Rapid remission of nephrotic-range proteinuria in a case of histologically proven diabetic nephropathy treated with an ACE inhibitor.
Open the PDF for in another window
Diabetes Care May 2000, Vol.23, 708-710. doi:https://doi.org/10.2337/diacare.23.5.708
Interesting insulin response to oral glucose load in young Japanese subjects with impaired glucose tolerance.
Y Tanaka; Y Atsumi; K Matsuoka; T Onuma; R Kawamori
View articletitled, Interesting insulin response to oral glucose load in young Japanese subjects with impaired glucose tolerance.
Open the PDF for in another window
Diabetes Care May 2000, Vol.23, 710-712. doi:https://doi.org/10.2337/diacare.23.5.710
Effect of gluten-free diet on the metabolic control of type 1 diabetes in patients with diabetes and celiac disease.
D Iafusco; F Rea; F Chiarelli; A Mohn; F Prisco
View articletitled, Effect of gluten-free diet on the metabolic control of type 1 diabetes in patients with diabetes and celiac disease.
Open the PDF for in another window
Diabetes Care May 2000, Vol.23, 712-713. doi:https://doi.org/10.2337/diacare.23.5.712a
An equation for insulin sensitivity index.
J S Cheng
View articletitled, An equation for insulin sensitivity index.
Open the PDF for in another window
Diabetes Care May 2000, Vol.23, 712. doi:https://doi.org/10.2337/diacare.23.5.712b
Is there any use for the oral glucose tolerance test?
O Vaccaro; G Ruffa; G Riccardi
View articletitled, Is there any use for the oral glucose tolerance test?
Open the PDF for in another window
Diabetes Care May 2000, Vol.23, 714-715. doi:https://doi.org/10.2337/diacare.23.5.714a
Prediction of albumin excretion rate from albumin-to-creatinine ratio.
T Cundy; J Baker
View articletitled, Prediction of albumin excretion rate from albumin-to-creatinine ratio.
Open the PDF for in another window
Diabetes Care May 2000, Vol.23, 714. doi:https://doi.org/10.2337/diacare.23.5.714b
Summary of Revisions: Standards of Care in Diabetes—2025
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2025
2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2025
Hyperglycemic Crises in Adults With Diabetes: A Consensus Report
Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring
  • Online ISSN 1935-5548
  • Print ISSN 0149-5992

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept